Skip to main content
Premium Trial:

Request an Annual Quote

ABI Licenses GE Healthcare's IP Covering Biomagnetic Isolation of DNA

NEW YORK (GenomeWeb News) — GE Healthcare today said Applied Biosystems has licensed its patents covering biomagnetic isolation of nucleic acids.
Under the agreement, ABI has access to the magnetic separation IP to isolate and purify nucleic acids through the duration of the patents, GE Healthcare said.
This technology is used with DNA and RNA from lab and clinical samples, and GE Healthcare said it offers higher yields and does not clog, which the company said is a drawback to filter-based isolation methods.
GE Healthcare said ABI plans to use the separation protocol with its MagMax isolation kits.
Financial terms of the agreement were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.